We are live on ! Find out more
HA

Havens Advisors Portfolio holdings

AUM $39.3M
1-Year Est. Return 80.07%
This Fund
S&P 500
This Quarter Est. Return
+34.22%
1 Year Est. Return
+80.07%
3 Year Est. Return
+460.15%
5 Year Est. Return
+1,430.14%
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$4.13M
Cap. Flow
-$12M
Cap. Flow %
-10.52%
Top 10 Hldgs %
70.46%
Holding
45
New
18
Increased
5
Reduced
4
Closed
14

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$7.54M
2
MDCO
Medicines Co
MDCO
+$5.2M
3
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$5.13M
4
TIF
Tiffany & Co.
TIF
+$3.06M
5
WBC
WABCO HOLDINGS INC.
WBC
+$2.83M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.6M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$7.88M
3
GWR
Genesee & Wyoming Inc.
GWR
+$5.69M
4
MDSO
Medidata Solutions, Inc.
MDSO
+$4.31M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 33.43%
2 Industrials 11.76%
3 Technology 11.56%
4 Consumer Discretionary 7.33%
5 Energy 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$13.7M 11.99%
71,500
+13,000
+22% +$2.35M
WCG
2
DELISTED
Wellcare Health Plans, Inc.
WCG
$13.6M 11.96%
41,300
+4,300
+12% +$1.29M
ADSW
3
DELISTED
Advanced Disposal Services Inc
ADSW
$10.3M 9.01%
312,500
+69,500
+29% +$2.28M
WMGI
4
DELISTED
Wright Medical Group Inc
WMGI
$8.77M 7.69%
+287,800
New +$7.54M
CY
5
DELISTED
Cypress Semiconductor
CY
$7.26M 6.36%
311,000
– –
MDCO
6
DELISTED
Medicines Co
MDCO
$6.63M 5.81%
+78,000
New +$5.2M
MLNX
7
DELISTED
Mellanox Technologies, Ltd.
MLNX
$5.93M 5.2%
50,600
-27,500
-35% -$3.12M
RARX
8
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$5.44M 4.77%
+116,000
New +$5.13M
WBC
9
DELISTED
WABCO HOLDINGS INC.
WBC
$4.41M 3.86%
32,510
+21,010
+183% +$2.83M
TGE
10
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$4.34M 3.8%
196,100
+80,324
+69% +$1.54M
TIF
11
DELISTED
Tiffany & Co.
TIF
$3.46M 3.04%
+25,900
New +$3.06M
CZR
12
DELISTED
Caesars Entertainment Corporation
CZR
$3.12M 2.73%
229,235
-132,765
-37% -$1.68M
ZAYO
13
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$3.07M 2.7%
88,700
– –
AXE
14
DELISTED
Anixter International Inc
AXE
$3.04M 2.67%
+33,000
New +$2.67M
ARQL
15
DELISTED
Arqule Inc
ARQL
$2.96M 2.6%
+148,500
New +$1.72M
QGEN icon
16
Qiagen
QGEN
$8.54B
$2.41M 2.11%
+67,146
New +$2.5M
S
17
DELISTED
Sprint Corporation
S
$2.14M 1.87%
410,000
-71,321
-15% -$418K
ACHN
18
DELISTED
Achillion Pharmaceuticals
ACHN
$1.69M 1.49%
+281,000
New +$1.63M
BOLD
19
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.59M 1.39%
+26,572
New +$997K
THOR
20
DELISTED
Synthorx, Inc. Common Stock
THOR
$1.54M 1.35%
+22,000
New +$628K
AMTD
21
DELISTED
TD Ameritrade Holding Corp
AMTD
$1.39M 1.22%
+28,000
New +$1.21M
TSG
22
DELISTED
The Stars Group Inc.
TSG
$1.08M 0.95%
+41,397
New +$927K
KEM
23
DELISTED
KEMET Corporation
KEM
$839K 0.74%
+31,000
New +$753K
AKS
24
DELISTED
AK Steel Holding Corp
AKS
$521K 0.46%
+158,250
New +$439K
FIT
25
DELISTED
Fitbit, Inc. Class A common stock
FIT
$512K 0.45%
+78,000
New +$458K
1
2

Similar funds

JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return
BGP
BrandyTrust Global Partners Hockessin, Delaware $35.4M AUM
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
EOCM
Energy Opportunities Capital Management Austin, Texas $34.4M AUM 54.2% 1-Year Est. Return
LN
Lewin Nick $31.5M AUM
ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
CL
Chubb Ltd Zurich, Switzerland $29.9M AUM 48.89% 1-Year Est. Return
ECM
Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return

Havens Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Havens Advisors held 45 positions worth $114M, up 3.8% from $110M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Havens Advisors withdrew a net $12M in Q4 2019, closing 14 positions and reducing 4 holdings. Its most notable exit was Celgene Corp, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 28% a quarter earlier, followed by Industrials and Technology.

Against the trend, Havens Advisors opened a new position in Wright Medical Group Inc worth $8.77M.

  • Havens Advisors's largest Q4 2019 buy was Wright Medical Group Inc: 287,800 shares worth $8.77M.
  • Havens Advisors added most to WABCO HOLDINGS INC. in Q4 2019, an estimated $2.83M increase.
  • Havens Advisors's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $3.12M.
  • Havens Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $14.6M.
  • Havens Advisors's ten largest holdings make up 70% of its $114M portfolio in Q4 2019.
  • Havens Advisors opened 18 new positions and closed 14 in Q4 2019.
  • Havens Advisors's portfolio value rose 3.8% quarter-over-quarter to $114M.

Based on Havens Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.